中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
9期
1230-1231
,共2页
董方%张兰%朱安礼%王志震%汤斌
董方%張蘭%硃安禮%王誌震%湯斌
동방%장란%주안례%왕지진%탕빈
利伐沙班%低分子肝素%股骨转子间骨折%PFNA%隐性失血
利伐沙班%低分子肝素%股骨轉子間骨摺%PFNA%隱性失血
리벌사반%저분자간소%고골전자간골절%PFNA%은성실혈
Rivaroxaban%Low molecular heparin%Intertrochanteric fractures%PFNA%Hidden blood
目的:比较利伐沙班与低分子肝素对PFNA固定股骨转子间骨折术后隐性失血的影响。方法:回顾分析我院骨科2010年05月至2012年10月收入的70例行PFNA固定的股骨转子间骨折患者,按照术后应用不同抗凝药物随机分为利伐沙班组、低分子肝素组,通过Gross方程计算出两组患者隐性失血量,比较两者差异。结果:利伐沙班组失血总量为(441.57±44.88)ml,隐性失血量为(361.43±33.22)ml,低分子肝素组失血总量为(486.43±37.64)ml,隐性失血量为(401.14±25.16)ml,两者差异有统计学意义(P<0.05)。结论:利伐沙班对PFNA固定股骨转子间骨折术后隐性失血的影响要小于低分子肝素。
目的:比較利伐沙班與低分子肝素對PFNA固定股骨轉子間骨摺術後隱性失血的影響。方法:迴顧分析我院骨科2010年05月至2012年10月收入的70例行PFNA固定的股骨轉子間骨摺患者,按照術後應用不同抗凝藥物隨機分為利伐沙班組、低分子肝素組,通過Gross方程計算齣兩組患者隱性失血量,比較兩者差異。結果:利伐沙班組失血總量為(441.57±44.88)ml,隱性失血量為(361.43±33.22)ml,低分子肝素組失血總量為(486.43±37.64)ml,隱性失血量為(401.14±25.16)ml,兩者差異有統計學意義(P<0.05)。結論:利伐沙班對PFNA固定股骨轉子間骨摺術後隱性失血的影響要小于低分子肝素。
목적:비교리벌사반여저분자간소대PFNA고정고골전자간골절술후은성실혈적영향。방법:회고분석아원골과2010년05월지2012년10월수입적70례행PFNA고정적고골전자간골절환자,안조술후응용불동항응약물수궤분위리벌사반조、저분자간소조,통과Gross방정계산출량조환자은성실혈량,비교량자차이。결과:리벌사반조실혈총량위(441.57±44.88)ml,은성실혈량위(361.43±33.22)ml,저분자간소조실혈총량위(486.43±37.64)ml,은성실혈량위(401.14±25.16)ml,량자차이유통계학의의(P<0.05)。결론:리벌사반대PFNA고정고골전자간골절술후은성실혈적영향요소우저분자간소。
[ABSTRACT]Objective:To compare the effects of rivaroxaban and low molecular heparin on hidden blood after PFNA treatment for intertrochanteric fractures.Methods:We retrospectively studied 70 patients with intertrochanteric fractured treated with PFNA between May 2010 and October 2012, 35 were assigned into the observation group of rivaroxaban and 35 into the control group of low molecular heparin, calculated the hidden blood in both groups by Gross equation, comparing differences between the two results. Results:The total blood loss was (441.57±44.88)ml,the hidden blood was (361.43±33.22)ml in group of rivaroxaban, and there was (486.43±37.64)ml of total blood loss and (401.14±25.16)ml of hidden blood in group of low molecular heparin, the difference was significant (P<0.05).Conclusion:The effect of rivaroxaban on hidden blood after PFNA treatment for intertrochanteric fractures was little than low molecular heparin.